Demand for GLP-1 weight loss drugs has reshaped the healthcare industry. And ETFs such as the Amplify Weight Loss Drug & Treatment ETF (THNR) give investors a way to access this growing market. What was once a small corner of the pharmaceutical market is now expected to become a $130 billion to $150 billion market by 2035. Key Takeaways - GLP-1 drugs have changed the weight loss market. As demand ...